Squamous And Non-Squamous Non-Small Cell Lung Cancer Websites
OPDIVO® (nivolumab) | Metastatic NSCLC | Healthcare Professionals Hom
OPDIVO® (nivolumab), for patients with previously treated metastatic non-small cell lung cancer (NSCLC). See Indication and Important Safety Information.
Not Applicable
$
8.95
